Published in PLoS One on September 18, 2008
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J (2009) 1.47
A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. J Neurosci (2013) 1.17
Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease. J Neurochem (2009) 1.17
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes. J Clin Invest (2014) 1.17
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry (2012) 1.11
The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res Ther (2010) 1.09
Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity. FEBS Lett (2013) 1.08
Hsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycle. J Biol Chem (2010) 1.01
Orchestration of secretory protein folding by ER chaperones. Biochim Biophys Acta (2013) 0.98
Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease. Aging (Albany NY) (2011) 0.95
Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radic Biol Med (2009) 0.92
Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol Cells (2011) 0.92
E. coli chaperones DnaK, Hsp33 and Spy inhibit bacterial functional amyloid assembly. Prion (2011) 0.87
Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells. J Biol Chem (2009) 0.85
Pre-amyloid oligomers of the proteotoxic RepA-WH1 prionoid assemble at the bacterial nucleoid. Sci Rep (2015) 0.82
Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast. Prion (2014) 0.80
Alzheimer's disease-associated peptide Aβ42 mobilizes ER Ca(2+) via InsP3R-dependent and -independent mechanisms. Front Mol Neurosci (2013) 0.80
Crystal structure of a conformation-dependent rabbit IgG Fab specific for amyloid prefibrillar oligomers. Biochim Biophys Acta (2012) 0.79
Involvement of ATP-sensitive potassium (K(ATP)) channels in the loss of beta-cell function induced by human islet amyloid polypeptide. J Biol Chem (2011) 0.79
Neuroprotective effects of treadmill exercise on BDNF and PI3-K/Akt signaling pathway in the cortex of transgenic mice model of Alzheimer's disease. J Exerc Nutrition Biochem (2013) 0.76
The elusive nature and diagnostics of misfolded Aβ oligomers. Front Chem (2015) 0.76
Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein. PLoS One (2012) 0.76
Alpha-synuclein oligomers: a new hope. Acta Neuropathol (2017) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Principles that govern the folding of protein chains. Science (1973) 23.40
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
Molecular chaperones in the cytosol: from nascent chain to folded protein. Science (2002) 15.09
Protein folding and misfolding. Nature (2003) 14.92
Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci (1993) 7.92
Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet (1998) 7.26
The crystal structure of the bacterial chaperonin GroEL at 2.8 A. Nature (1994) 6.72
Structural analysis of substrate binding by the molecular chaperone DnaK. Science (1996) 6.13
Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature (2006) 5.42
Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (2006) 5.39
Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci (2005) 5.00
Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A (2002) 4.66
Amyloid fibrils from muscle myoglobin. Nature (2001) 3.93
The crystal structure of diphtheria toxin. Nature (1992) 3.80
Crystal structure of firefly luciferase throws light on a superfamily of adenylate-forming enzymes. Structure (1996) 3.51
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc Natl Acad Sci U S A (1986) 3.41
Structural basis of interdomain communication in the Hsc70 chaperone. Mol Cell (2005) 3.34
Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J (1997) 2.92
The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state. Cell (2003) 2.89
Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol (2006) 2.82
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J (2002) 2.59
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
A native to amyloidogenic transition regulated by a backbone trigger. Nat Struct Mol Biol (2006) 2.20
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci U S A (2004) 2.14
The crystal structure of the yeast Hsp40 Ydj1 complexed with its peptide substrate. Structure (2003) 1.97
The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity. Cell (1999) 1.96
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A (1994) 1.94
Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci U S A (2008) 1.88
Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem (2006) 1.86
Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci U S A (1997) 1.79
General structural motifs of amyloid protofilaments. Proc Natl Acad Sci U S A (2006) 1.72
The Yin and Yang of protein folding. FEBS J (2005) 1.68
The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. Structure (2004) 1.63
Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci (2002) 1.51
Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature (1977) 1.51
Arrangement of subunits and ordering of beta-strands in an amyloid sheet. Nat Struct Biol (2002) 1.43
Plasticity of amyloid fibrils. Biochemistry (2007) 1.43
Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res (2006) 1.28
Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol (2005) 1.25
Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci U S A (1998) 1.15
Direct observation of the multistep helix formation of poly-L-glutamic acids. J Am Chem Soc (2002) 1.07
Structural plasticity and noncovalent substrate binding in the GroEL apical domain. A study using electrospay ionization mass spectrometry and fluorescence binding studies. J Biol Chem (2002) 0.98
Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation. Ciba Found Symp (1996) 0.96
Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem (1998) 0.93
Chaperonin-mediated de novo generation of prion protein aggregates. J Mol Biol (2001) 0.92
Crystal structure of the receptor-binding domain of alpha 2-macroglobulin. Structure (1998) 0.88
Antibodies as specific chaperones. Biochemistry (Mosc) (2004) 0.82
Monoclonal antibodies assisting refolding of firefly luciferase. Protein Sci (2004) 0.79
Development of series of gateway binary vectors, pGWBs, for realizing efficient construction of fusion genes for plant transformation. J Biosci Bioeng (2007) 7.98
A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell (2003) 3.96
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron (2013) 3.27
Improved Gateway binary vectors: high-performance vectors for creation of fusion constructs in transgenic analysis of plants. Biosci Biotechnol Biochem (2007) 2.91
Single-base resolution methylomes of tomato fruit development reveal epigenome modifications associated with ripening. Nat Biotechnol (2013) 2.43
Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A (2003) 2.32
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. AIDS Res Hum Retroviruses (2007) 2.19
Aluminum induces tau aggregation in vitro but not in vivo. J Alzheimers Dis (2007) 2.10
Granular tau oligomers as intermediates of tau filaments. Biochemistry (2007) 1.67
In vivo evidence of CHIP up-regulation attenuating tau aggregation. J Neurochem (2005) 1.66
Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci U S A (2002) 1.66
Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem (2003) 1.64
Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci (2004) 1.63
Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1. J Virol (2006) 1.59
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci (2007) 1.58
Exploration of novel motifs derived from mouse cDNA sequences. Genome Res (2002) 1.51
Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease. Neurosci Res (2006) 1.49
Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol (2003) 1.47
Moderate physical exercise increases cardiac autonomic nervous system activity in children with low heart rate variability. Childs Nerv Syst (2004) 1.46
Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment. Circ J (2015) 1.45
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin - Insights From the ENGAGE AF-TIMI 48 Trial. Circ J (2015) 1.44
Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci (2002) 1.42
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis. Circ J (2016) 1.39
Giant mediastinal bronchial artery aneurysm mimicking benign esophageal tumor: a case report and review of 26 cases from literature. J Vasc Surg (2003) 1.33
Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur J Neurosci (2007) 1.31
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget (2012) 1.30
GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin. PLoS One (2008) 1.26
Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem (2002) 1.23
Surface structure of amyloid-beta fibrils contributes to cytotoxicity. Biochemistry (2007) 1.23
Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis (2006) 1.23
Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau. EMBO J (2007) 1.22
Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res (2010) 1.21
Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loop. AIDS Res Hum Retroviruses (2010) 1.21
Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum Mol Genet (2006) 1.20
Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy. J Biol Chem (2002) 1.19
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. Structure (2004) 1.19
Electrical stimulation modulates fate determination of differentiating embryonic stem cells. Stem Cells (2006) 1.18
Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. J Neurosci (2008) 1.15
Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. J Biol Chem (2003) 1.13
Characterization of the interaction between interleukin-13 and interleukin-13 receptors. J Biol Chem (2005) 1.12
Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromolecular Med (2007) 1.12
Development of R4 gateway binary vectors (R4pGWB) enabling high-throughput promoter swapping for plant research. Biosci Biotechnol Biochem (2008) 1.11
Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. J Neurosci (2011) 1.11
GSK-3beta is required for memory reconsolidation in adult brain. PLoS One (2008) 1.11
Microtubule-associated protein tau is essential for long-term depression in the hippocampus. Philos Trans R Soc Lond B Biol Sci (2013) 1.10
Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun (2003) 1.09
Solution structure of a BolA-like protein from Mus musculus. Protein Sci (2004) 1.07
Characterization of a cellulase containing a family 30 carbohydrate-binding module (CBM) derived from Clostridium thermocellum CelJ: importance of the CBM to cellulose hydrolysis. J Bacteriol (2003) 1.07
Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J Biol Chem (2004) 1.06
Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding. J Biol Chem (2012) 1.05
The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates. J Biol Chem (2013) 1.05
Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss. J Biol Chem (2010) 1.04
Hybrid technique of cortical bone trajectory and pedicle screwing for minimally invasive spine reconstruction surgery: a technical note. J Med Invest (2014) 1.03
U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy. J Neurochem (2004) 1.03
Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin. J Immunol (2011) 1.02
Comparative study on the structure and cytopathogenic activity of HIV Vpr/Vpx proteins. Microbes Infect (2005) 1.02
Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood (2009) 1.01
Bioengineering a humanized acne microenvironment model: proteomics analysis of host responses to Propionibacterium acnes infection in vivo. Proteomics (2008) 1.01
Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J Biol Chem (2003) 1.00
Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem (2006) 0.99
Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells (2011) 0.99
Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis. Cancer Res (2012) 0.99
Method for comparing the structures of protein ligand-binding sites and application for predicting protein-drug interactions. Proteins (2008) 0.98
Generation of high-affinity antibody against T cell-dependent antigen in the Ganp gene-transgenic mouse. J Immunol (2005) 0.97
A ganglioside-induced toxic soluble Abeta assembly. Its enhanced formation from Abeta bearing the Arctic mutation. J Biol Chem (2006) 0.96
In vivo functional brain mapping in a conditional mouse model of human tauopathy (tauP301L) reveals reduced neural activity in memory formation structures. Mol Neurodegener (2013) 0.95
The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res (2008) 0.95
Electrical stimulation of human lower extremities enhances energy consumption, carbohydrate oxidation, and whole body glucose uptake. J Appl Physiol (1985) (2003) 0.95
Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity. Small (2012) 0.95
Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer's beta-amyloid proteins. J Neurosci Res (2006) 0.95
Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation. J Biol Chem (2011) 0.95
Interaction between a type-II dockerin domain and a type-II cohesin domain from Clostridium thermocellum cellulosome. Biosci Biotechnol Biochem (2004) 0.94
Autophagy: resetting glutamine-dependent metabolism and oxygen consumption. Autophagy (2012) 0.94
Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer (2014) 0.93
Essential role of the family-22 carbohydrate-binding modules for beta-1,3-1,4-glucanase activity of Clostridium stercorarium Xyn10B. FEBS Lett (2004) 0.93
Characterization of Paenibacillus curdlanolyticus intracellular xylanase Xyn10B encoded by the xyn10B gene. Biosci Biotechnol Biochem (2010) 0.92
Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder. Biopsychosoc Med (2007) 0.92
Sacsin-related autosomal recessive ataxia without prominent retinal myelinated fibers in Japan. Mov Disord (2005) 0.92
The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. Proc Natl Acad Sci U S A (2002) 0.91
Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs. Am J Physiol Heart Circ Physiol (2004) 0.91
Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro. Exp Neurol (2004) 0.91
Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro. J Neurochem (2002) 0.90
Selective fatigue of fast motor units after electrically elicited muscle contractions. J Electromyogr Kinesiol (2004) 0.90
Enrichment of anammox bacteria from marine environment for the construction of a bioremediation reactor. Appl Microbiol Biotechnol (2007) 0.90
Autonomic nervous system activity and psychiatric severity in schizophrenia. Psychiatry Clin Neurosci (2009) 0.90
Identification of an AAA ATPase VPS4B-dependent pathway that modulates epidermal growth factor receptor abundance and signaling during hypoxia. Mol Cell Biol (2012) 0.90
Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells. Biochem Pharmacol (2010) 0.90
Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis. J Immunol (2012) 0.89
Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice. Brain Res (2005) 0.89
Complete dosage compensation and sex-biased gene expression in the moth Manduca sexta. Genome Biol Evol (2014) 0.89
Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep (2010) 0.89
Molecular structure of amyloid fibrils formed by residues 127 to 147 of the human prion protein. Chemistry (2010) 0.89
Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS (2006) 0.88
The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J Biol Chem (2003) 0.88
alpha-Galactosidase Aga27A, an enzymatic component of the Clostridium josui cellulosome. J Bacteriol (2002) 0.88
State of the art: Intraoperative neuromonitoring in spinal deformity surgery. J Med Invest (2015) 0.88